Charles River Laboratories International, Inc. (CRL) Financial Statements (2023 and earlier)

Company Profile

Business Address 251 BALLARDVALE ST
WILMINGTON, MA 01887
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)
Annual | Quarterly

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments242229239196164118118
Cash and cash equivalents241228238195164118118
Short-term investments1111   
Restricted cash and investments4300  0
Receivables650618514472430364270
Inventory, net of allowances, customer advances and progress billings1991861611281159694
Inventory1991861611281159694
Prepaid expense94975353373430
Other current assets  008145 
Other undisclosed current assets85685447  47
Total current assets:1,2741,2011,021898827657559
Noncurrent Assets
Operating lease, right-of-use asset293178140✕✕✕✕
Property, plant and equipment 1,1241,044933782756678
Long-term investments and receivables      62
Long-term investments      62
Intangible assets, net (including goodwill)3,7732,5972,2301,8581,1751,182720
Goodwill2,7121,8091,5411,247805788439
Intangible assets, net (excluding goodwill)1,061788689611370394281
Deferred income tax assets403845✕✕✕✕
Other noncurrent assets3533532131441248872
Other undisclosed noncurrent assets1,291  232329(22)
Total noncurrent assets:5,7504,2903,6712,9582,1032,0551,509
TOTAL ASSETS:7,0245,4914,6933,8562,9302,7122,068
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities673479409310269246199
Accounts payable19812211166786837
Accrued liabilities229150139107908489
Employee-related liabilities2462071591371019373
Deferred revenue220208172✕✕✕✕
Debt3503931312717
Disposal group, including discontinued operation    222
Deferred revenue and credits✕✕✕✕11812881
Contract with customer, liability✕✕✕145✕✕✕
Other liabilities1381029171442713
Total current liabilities:1,033840710558464430312
Noncurrent Liabilities
Long-term debt and lease obligation, including:2,6641,9301,8501,6371,1141,208846
Long-term debt, excluding current maturities   1,6271,0921,188821
Finance lease, liability252628✕✕✕✕
Operating lease, liability253156116✕✕✕✕
Other undisclosed long-term debt and lease obligation2,3861,7481,70610222025
Liabilities, other than long-term debt583495429238287221145
Deferred tax liabilities, net✕✕✕  5648
Deferred income tax liabilities240217167✕✕✕✕
Liability, pension and other postretirement and postemployment benefits7573795989  
Disposal group, including discontinued operation, liabilities    468
Other liabilities24320518317919515989
Business combination, contingent consideration, liability25      
Other undisclosed noncurrent liabilities1538337841  
Total noncurrent liabilities:3,3992,5072,3161,9591,4021,428991
Total liabilities:4,4323,3473,0262,5181,8661,8581,303
Temporary equity, carrying amount53252919171528
Stockholders' equity
Stockholders' equity attributable to parent2,5352,1151,6351,3171,045837733
Common stock1000111
Treasury stock, value   (0)(1,660)(1,553)(1,541)
Additional paid in capital1,7181,6281,5321,4482,5602,4772,398
Accumulated other comprehensive loss(165)(139)(178)(173)(145)(254)(136)
Retained earnings9816252804228916511
Stockholders' equity attributable to noncontrolling interest4432224
Total stockholders' equity:2,5392,1181,6381,3201,047839738
TOTAL LIABILITIES AND EQUITY:7,0245,4914,6933,8562,9302,7122,068

Income Statement (P&L) ($ in millions)
Annual | Quarterly

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues3,5402,9242,6212,2661,8581,6811,363
Revenue, net✕✕✕✕1,8581,6811,363
Cost of revenue
(Cost of Goods and Services Sold)		    (1,155)(1,035)(832)
Gross profit:3,5402,9242,6212,266702647531
Operating expenses(745)(641)(607)(509)(415)(409)(325)
Other undisclosed operating loss(2,206)(1,850)(1,663)(1,426)   
Operating income:590433351331287237206
Nonoperating income (expense)(35)101141439134
Investment income, nonoperating1121111
Other nonoperating income (expense)(36)100121339123
Interest and debt expense(74)(86)(61)(64)(30)(28)(15)
Income from continuing operations before income taxes:481447304282297223195
Income tax expense(82)(82)(50)(54)(171)(67)(43)
Income from continuing operations:399365254227126156152
Income (loss) from discontinued operations   2(0)0(1)
Net income:399365254229125156151
Net loss attributable to noncontrolling interest(8)(1)(2)(2)(2)(2)(2)
Net income available to common stockholders, diluted:391364252226123155149

Comprehensive Income ($ in millions)
Annual | Quarterly

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income:399365254229125156151
Other comprehensive income (loss)4(15)(5)(25)109(118)(61)
Other undisclosed comprehensive income (loss)(29)56(0)(1)1(1)(1)
Comprehensive income:3744062492032363789
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(9)(2)(2)(1)(3)0(1)
Comprehensive income, net of tax, attributable to parent:3654032472022323788

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: